Manic Fringe anticorps
Aperçu rapide pour Manic Fringe anticorps (ABIN7183808)
Antigène
Voir toutes Manic Fringe (MFNG) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- MFNG Antibody
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from internal of Human MFNG.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Manic Fringe (MFNG) (MFNG)
-
Autre désignation
- MFNG
-
Sujet
-
Background: Glycosyltransferase involved in the elongation of O-linked ligands to activate Notch signaling. Possesses fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity.
Johnston S.H., Development 124:2245-2254(1997).
Collins J.E., Genome Biol. 5:R84.1-R84.11(2004).
Dunham I., Nature 402:489-495(1999).Aliases: 3-N-acetylglucosaminyltransferase manic fringe antibody, Beta-1 antibody, Beta-1,3-N-acetylglucosaminyltransferase manic fringe antibody, MFNG antibody, MFNG_HUMAN antibody, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase antibody
-
UniProt
- O00587
-
Pathways
- Signalisation Notch
Antigène
-